289 related articles for article (PubMed ID: 26410176)
1. Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low-dose combined oral contraceptive.
Nakajima ST; Pappadakis J; Archer DF
Contraception; 2016 Jan; 93(1):52-7. PubMed ID: 26410176
[TBL] [Abstract][Full Text] [Related]
2. Norethindrone acetate 1.0 milligram and ethinyl estradiol 10 micrograms as an ultra low-dose oral contraceptive.
Archer DF; Nakajima ST; Sawyer AT; Wentworth J; Trupin S; Koltun WD; Gilbert RD; Ellman H
Obstet Gynecol; 2013 Sep; 122(3):601-7. PubMed ID: 23921878
[TBL] [Abstract][Full Text] [Related]
3. A new ultra-low-dose combination oral contraceptive.
Woutersz TB
J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe).
Nakajima ST; Archer DF; Ellman H
Contraception; 2007 Jan; 75(1):16-22. PubMed ID: 17161118
[TBL] [Abstract][Full Text] [Related]
5. Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.
Merz M; Kroll R; Lynen R; Bangerter K
Contraception; 2015 Feb; 91(2):113-20. PubMed ID: 25453585
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with a low dose oral contraceptive containing norethisterone and ethinyl oestradiol.
Morigi EM; Pasquale SA
Curr Med Res Opin; 1978; 5(8):655-62. PubMed ID: 710178
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
Weisberg E; Merki-Feld GS; McGeechan K; Fraser IS
Contraception; 2015 Feb; 91(2):121-6. PubMed ID: 25459098
[TBL] [Abstract][Full Text] [Related]
8. Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetate.
Rible RD; Taylor D; Wilson ML; Stanczyk FZ; Mishell DR
Contraception; 2009 Mar; 79(3):182-8. PubMed ID: 19185670
[TBL] [Abstract][Full Text] [Related]
9. Pooled analysis of two randomized, open-label studies comparing the effects of nomegestrol acetate/17β-estradiol and drospirenone/ethinyl estradiol on bleeding patterns in healthy women.
Mansour D; Westhoff C; Kher U; Korver T
Contraception; 2017 Apr; 95(4):390-397. PubMed ID: 28011288
[TBL] [Abstract][Full Text] [Related]
10. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
Edelman AB; Koontz SL; Nichols MD; Jensen JT
Obstet Gynecol; 2006 Mar; 107(3):657-65. PubMed ID: 16507938
[TBL] [Abstract][Full Text] [Related]
11. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial.
Teichmann A; Apter D; Emerich J; Greven K; Klasa-Mazurkiewicz D; Melis GB; Spaczynski M; Grubb GS; Constantine GD; Spielmann D
Contraception; 2009 Dec; 80(6):504-11. PubMed ID: 19913143
[TBL] [Abstract][Full Text] [Related]
12. Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO.
Poindexter AN; Burkman R; Fisher AC; LaGuardia KD
Int J Fertil Womens Med; 2003; 48(4):163-72. PubMed ID: 13677549
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive.
Portman DJ; Kaunitz AM; Howard B; Weiss H; Hsieh J; Ricciotti N
Contraception; 2014 Apr; 89(4):299-306. PubMed ID: 24576794
[TBL] [Abstract][Full Text] [Related]
14. Urinary estrogen and serum gonadotropin profiles in women ingesting oral contraceptive steroid formulations with variable estrogen content.
Grimes EM; Thompson IE; Taymor ME
J Natl Med Assoc; 1983 Jun; 75(6):575-80. PubMed ID: 6410078
[TBL] [Abstract][Full Text] [Related]
15. 20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception.
Gallo MF; Nanda K; Grimes DA; Schulz KF
Cochrane Database Syst Rev; 2005 Apr; (2):CD003989. PubMed ID: 15846690
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of two low-dose combined oral contraceptives: results from a multicenter trial.
Dunson TR; McLaurin VL; Israngkura B; Leelapattana B; Mukherjee R; Perez-Palacios G; Saleh AA
Contraception; 1993 Aug; 48(2):109-19. PubMed ID: 8403908
[TBL] [Abstract][Full Text] [Related]
17. Association between efficacy and body weight or body mass index for two low-dose oral contraceptives.
Burkman RT; Fisher AC; Wan GJ; Barnowski CE; LaGuardia KD
Contraception; 2009 Jun; 79(6):424-7. PubMed ID: 19442776
[TBL] [Abstract][Full Text] [Related]
18. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
19. Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other oral contraceptives.
Garceau RJ; Wajszczuk CJ; Kaunitz AM;
Contraception; 2000 Dec; 62(6):289-95. PubMed ID: 11239615
[TBL] [Abstract][Full Text] [Related]
20. Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives.
Hampton RM; Zhang HF; Barnowski C; Wan GJ
Contraception; 2008 Jun; 77(6):415-9. PubMed ID: 18477490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
